Search Within

Kevin Joseph Curran

  1. "CTCR Scholars"
Formats
  1. Meeting Abstract (7)
  2. Journal Article (5)
Groups
  1. Bone Marrow Transplant (12)
  2. CTCR Scholars (12)
  3. Center for Hematologic Malignancies (12)
  4. Department of Medicine (12)
  5. Hematologic Malignancies, Division of (12)
  6. Pediatrics, Department of (12)

More Groups

People
  1. Sergio Giralt (10)
  2. Ann Jakubowski (9)
  3. Esperanza Papadopoulos (9)
  4. Farid Boulad (9)
  5. Miguel-Angel Perales (9)
  6. Nancy Kernan (9)

More People

Years
  1. 2024 (3)
  2. 2023 (2)
  3. 2022 (1)
  4. 2020 (3)
  5. 2018 (1)
  6. 2015 (1)

More Years

Publications
  1. Blood (3)
  2. Bone Marrow Transplantation (3)
  3. Blood Advances (2)
  4. Journal of Clinical Investigation (2)
  5. Biology of Blood and Marrow Transplantation (1)
  6. Journal of the American Academy of Dermatology (1)
Publishers
  1. American Society of Hematology (5)
  2. Nature Publishing Group (3)
  3. American Society for Clinical Investigation (2)
  4. Elsevier Inc. (1)
  5. Mosby Elsevier (1)

Results (12)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of pharmacokinetic model-based ATG dosing to improve survival through enhanced immune reconstitution in patients undergoing ex vivo CD34-selected allogeneic HCT (PRAISE-IR)
    Meeting Abstract

    Scordo, M.; Perales, M. A.; Mauguen, A.; Lin, A.; Kunvarjee, B.; Bieler, J.; Nguyen, L. K.; Paes Pena, M.; Cho, C.; Gyurkocza, B.; more...
    Bone Marrow Transplantation (2024)

    Fulltext@MSK | Save
  • Dermatologic adverse events following CD19-directed CAR T-cell therapy in hematologic malignancies
    Meeting Abstract

    Storgard, R.; Reingold, R.; Parisi, R.; Dusza, S.; Noor, S.; Park, J.; Sauter, C.; Curran, K.; Perales, M.; Scordo, M.; more...
    Journal of the American Academy of Dermatology (2024)

    Fulltext@MSK | Save
  • T-cell depleted allogeneic hematopoietic stem cell transplant for the treatment of Fanconi anemia and MDS/AML
    Journal Article

    Satty, A. M.; Klein, E.; Mauguen, A.; Kunvarjee, B.; Boelens, J. J.; Cancio, M.; Curran, K. J.; Kernan, N. A.; Prockop, S. E.; Scaradavou, A.; more...
    Bone Marrow Transplantation (2024)

    Fulltext@MSK | Save
  • Association between busulfan exposure and survival in patients undergoing a CD34(+) selected stem cell transplantation
    Journal Article

    Tamari, R.; Scordo, M.; Kunvarjee, B. M.; Proli, A.; Lin, A.; Flynn, J.; Cho, C.; Devlin, S.; Klein, E.; Boulad, F.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant
    Journal Article

    Prockop, S. E.; Hasan, A.; Doubrovina, E.; Dahi, P. B.; Rodriguez-Sanchez, I.; Curry, M.; Mauguen, A.; Papanicolaou, G. A.; Su, Y.; Yao, J.; more...
    Journal of Clinical Investigation (2023)

    Fulltext@MSK | Save
  • Antithymocyte globulin exposure in CD34(+) T-cell–depleted allogeneic hematopoietic cell transplantation
    Journal Article

    Lakkaraja, M.; Scordo, M.; Mauguen, A.; Cho, C.; Devlin, S.; Ruiz, J. D.; Klein, E.; Avecilla, S. T.; Boulad, F.; Cancio, M. I.; more...
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Rabbit anti-thymocyte globulin exposure (rATG) in CD34+ selected hematopoietic cell transplantation and its impact on immune reconstitution and outcomes in children and adults
    Meeting Abstract

    Lakkaraja, M.; Scordo, M.; Mauguen, A.; Cho, C.; Devlin, S.; Avecilla, S. T.; Boulad, F.; Cancio, M. I.; Curran, K. J.; Jakubowski, A. A.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Outcomes of two chemotherapy-based preparatory regimens compared to tbi-based conditioning when used with CD34(+) selected T-cell depleted alloHCT for high risk hematologic malignancies: Prospective clinical trial NCT 01119066
    Meeting Abstract

    O'Reilly, R. J.; Koehne, G.; Boulad, F.; Heller, G.; Klein, E.; Barker, J. N.; Castro-Malaspina, H.; Curran, K. J.; Hsu, K. C.; Jakubowski, A. A.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation
    Journal Article

    Prockop, S.; Doubrovina, E.; Suser, S.; Heller, G.; Barker, J.; Dahi, P.; Perales, M. A.; Papadopoulos, E.; Sauter, C.; Castro-Malaspina, H.; more...
    Journal of Clinical Investigation (2020)

    Fulltext@MSK | Save
  • Clinical responses and pharmacokinetics of MCARH171, a human-derived BCMA targeted CAR T cell therapy in relapsed/refractory multiple myeloma: Final results of a phase I clinical trial
    Meeting Abstract

    Mailankody, S.; Ghosh, A.; Staehr, M.; Purdon, T. J.; Roshal, M.; Halton, E.; Diamonte, C.; Pineda, J.; Anant, P.; Bernal, Y.; more...
    Blood (2018)

    Fulltext@MSK | Save